Showing results (1971-1980 of 2,138) with videos related to

Sort By:
Pageof 214
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Heterobiaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part IIMichael P Trova, Keith D Barnes, Luis Alicea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGD Nitti, J Wils, J Guimaraes Dos Santos, et al.
Scientific Reports|December 15, 2020
Impact of individual demographic and social factors on human-wildlife interactions: a comparative study of three macaque speciesKrishna N Balasubramaniam, Pascal R Marty, Shelby Samartino, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane studyJudith M Bliss, Lucy S Kilburn, Robert E Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trialI E Smith, R P A'Hern, G A Coombes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†V Speirs, G Viale, K Mousa, et al.
NPJ Breast Cancer|June 19, 2020
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemicMitch Dowsett, Matthew J Ellis, J Michael Dixon, et al.
Current Biology : CB|May 29, 2012
The chemical interactions underlying tomato flavor preferencesDenise Tieman, Peter Bliss, Lauren M McIntyre, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Pageof 214